Skip to main content
Log in

Fixed-dosage monoclonal antibodies save costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2020 euros

Reference

  • Heinhuis KM, et al. A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute. International Journal of Clinical Pharmacy : 10 Sep 2020. Available from: URL: http://doi.org/10.1007/s11096-020-01131-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fixed-dosage monoclonal antibodies save costs. PharmacoEcon Outcomes News 863, 15 (2020). https://doi.org/10.1007/s40274-020-7169-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7169-7

Navigation